Acadia: 3Q Earnings Snapshot
SAN DIEGO (AP) _ Acadia Pharmaceuticals Inc. (ACAD) on Tuesday reported a loss of $62.1 million in its third quarter.
The San Diego-based company said it had a loss of 50 cents per share.
The results exceeded Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 58 cents per share.
The drugmaker posted revenue of $58.3 million in the period, which also beat Street forecasts. Four analysts surveyed by Zacks expected $57.9 million.
Acadia shares have dropped 27 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $21.88, a fall of 33 percent in the last 12 months.